Glycolysis Inhibition Functionally Reprograms T Follicular Helper Cells and Reverses Lupus

Scientists investigated the mechanisms by which the glycolysis inhibitor 2-deoxy-d-glucose reduces the expansion of T follicular helper cells and the associated production of autoantibodies in lupus-prone mice.